Taysha Gene Therapies Inc (TSHA) — Financial Flexibility Index
Taysha Gene Therapies Inc (TSHA) has a Financial Flexibility Index of -0.46x as of March 2026. Free cash flow of $-40.85 Million (operating CF $-40.88 Million minus capex $24.00K) represents 0% of total liabilities ($88.41 Million). Also explore Taysha Gene Therapies Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Taysha Gene Therapies Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Taysha Gene Therapies Inc across 7 annual periods. Check strategic asset allocation of Taysha Gene Therapies Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Taysha Gene Therapies Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Taysha Gene Therapies Inc. For the full company profile including market capitalisation, see Taysha Gene Therapies Inc (TSHA) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.96x | $-92.35 Million | $-93.09 Million | $96.38 Million | ▼ -5.3% |
| 2024 | -0.91x | $-80.85 Million | $-81.22 Million | $88.84 Million | ▼ -35.6% |
| 2023 | -0.67x | $-65.65 Million | $-73.02 Million | $97.79 Million | ▼ -32.4% |
| 2022 | -0.51x | $-63.52 Million | $-88.39 Million | $125.33 Million | ▲ +37.1% |
| 2021 | -0.81x | $-95.49 Million | $-117.04 Million | $118.57 Million | ▲ +71.8% |
| 2020 | -2.86x | $-21.65 Million | $-30.73 Million | $7.58 Million | ▼ -297.4% |
| 2019 | 1.45x | $217.00K | $135.00K | $150.00K | — |